These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9745991)

  • 1. Clues for understanding the pathogenesis of left ventricular hypertrophy in chronic uremia.
    Cannella G; Paoletti E
    Int J Artif Organs; 1998 Jul; 21(7):378-83. PubMed ID: 9745991
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular abnormalities in end stage renal failure: the effect of anaemia or uraemia?
    Morris KP; Skinner JR; Hunter S; Coulthard MG
    Arch Dis Child; 1994 Aug; 71(2):119-22. PubMed ID: 7944530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

  • 4. Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it?
    Dyadyk OI; Bagriy AE; Yarovaya NF
    Eur J Heart Fail; 1999 Dec; 1(4):327-36. PubMed ID: 10937946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Imaging modalities for evaluation of cardiac function in patients with chronic hemodialysis].
    Komiyama N
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():92-5. PubMed ID: 15250275
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular disease and atherosclerosis in uremia.
    London GM
    Blood Purif; 2001; 19(2):139-42. PubMed ID: 11150800
    [No Abstract]   [Full Text] [Related]  

  • 7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD).
    Buoncristiani U; Fagugli RM; Pinciaroli MR; Kulurianu H; Ceravolo G; Bova C
    Contrib Nephrol; 1996; 119():152-6. PubMed ID: 8783607
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S; Hennig L; Sternberg C; Dingerkus H; Ludat K; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and cerebrovascular disease in chronic uremia.
    Parfrey PS
    Am J Kidney Dis; 1993 Jan; 21(1):77-80. PubMed ID: 8418631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac systolic and diastolic function in children on hemodialysis and continuous ambulatory peritoneal dialysis.
    Litwin M; Kawalec W; Latoszyńska J; Grenda R; Smirska E
    Contrib Nephrol; 1994; 106():114-8. PubMed ID: 8174354
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does erythropoietin restrict lef ventricular hypertrophy in patients with chronic renal failure?].
    Switalski M; Boniecka Z; Gellert R
    Pol Arch Med Wewn; 2002 Apr; 107(4):389-92. PubMed ID: 12189932
    [No Abstract]   [Full Text] [Related]  

  • 15. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.
    Cannella G; Paoletti E; Ravera G; Cassottana P; Araghi P; Mulas D; Peloso G; Delfino R; Messa P
    Kidney Int; 2000 Jul; 58(1):260-8. PubMed ID: 10886571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we overestimating left ventricular abnormalities in end-stage renal disease?
    Mark PB; Patel RK; Jardine AG
    Nephrol Dial Transplant; 2007 Jul; 22(7):1815-9. PubMed ID: 17438003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Left ventricular hypertrophy in end-stage renal disease and its possible regression as a result of correction of anemia and arterial hypertension].
    Dzgoeva FU; Gatagonova TM; Kadzaeva ZK; Khamitsaeva OV; Kochisova ZKh; Dzutseva AT; Bazaeva BG
    Ter Arkh; 2011; 83(6):42-6. PubMed ID: 21786575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy in the dialysed patient. What can be done about it?
    Cannella G
    Nephrol Dial Transplant; 1996 Mar; 11(3):418-20. PubMed ID: 8671807
    [No Abstract]   [Full Text] [Related]  

  • 20. [Left ventricle hypertrophy as a sudden death risk factor in patients with chronic kidney failure treated with hemodialysis].
    Wanic-Kossowska M; Płotast J; Lehman P; Czarnecki R; Czekalski S
    Pol Arch Med Wewn; 1999 Aug; 102(2):725-31. PubMed ID: 10948707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.